Marcy B. Bolster

Cyclophosphamide versus Placebo in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · New England Journal of Medicine · 2006 · 1.7K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy of Tocilizumab in Patients Hospitalized with Covid-19

John H. Stone, Matthew J. Frigault, Naomi Serling‐Boyd et al. · New England Journal of Medicine · 2020 · 1.4K citations · Full text

Medicine, Infectious Diseases, Pharmacotherapy +17

Effects of 1-Year Treatment with Cyclophosphamide on Outcomes at 2 Years in Scleroderma Lung Disease

Donald P. Tashkin, Robert M. Elashoff, Philip J. Clements et al. · American Journal of Respiratory and Critical Care Medicine · 2007 · 464 citations · Full text

Medicine, Internal Medicine, Pharmacotherapy +15

2015 American College of Rheumatology Workforce Study: Supply and Demand Projections of Adult Rheumatology Workforce, 2015–2030

Daniel F. Battafarano, Marcia Ditmyer, Marcy B. Bolster et al. · Arthritis Care & Research · 2018 · 284 citations · Full text

Nursing, Physician Assistant Studies, Nurse Practitioner Practice +16

Survival and Predictors of Mortality in Systemic Sclerosis‐Associated Pulmonary Arterial Hypertension: Outcomes From the Pulmonary Hypertension Assessment and Recognition of Outcomes in Scleroderma Registry

Robyn T. Domsic, Bharathi Lingala, Firas Alkassab et al. · Arthritis Care & Research · 2013 · 171 citations · Full text

Medicine, Cardiology, Clinical Sciences +11